Screen Selection Sample Clauses

Screen Selection. Attached as Exhibit 1.35 is a list of at least *** Organon Targets for ***. Additional potential Organon Targets (at least *** and of *** listed on Exhibit A, with a *** by ***; i.e *** and *** or ***, e.g., ***, etc.) will be presented by Organon to Aurora at *** days prior to the *** of the Effective Date during the Collaboration Period. Aurora will develop Collaborative Screens for at least *** Organon Targets (of which *** unless otherwise agreed by the CSP Steering Committee) in the ***, of the Collaborative Period, *** Collaborative Screens for Organon Targets (of which *** may be *** unless otherwise agreed by the CSP Steering Committee) in the *** of the Collaborative Period, subject to Sections 2.1.3.3 and 2.1.3.4. *** Confidential Treatment Requested
Sample 1
AutoNDA by SimpleDocs
Screen Selection. Within *** of the Effective Date PD will begin to propose in writing to Aurora molecular targets. For each proposed molecular target, PD shall provide Aurora with a written proposal describing such target. Within thirty (30) days of receiving such information, and further information as Aurora may
Sample 1
Screen Selection. Within fifteen (15) days after the Effective Date, and at least ninety (90) days prior to the first, second, third and fourth anniversaries of the Effective Date, Merck will propose in writing to Aurora molecular targets which Merck believes are reasonably feasible for development of screens for the next Annual Work Plan. For each proposed molecular target, Merck shall provide Aurora with a written proposal describing such molecular target. Within thirty (30) days after the Effective Date, and in subsequent years, within forty-five (45) days after receiving such information from Merck, and further information as Aurora may reasonably request regarding a proposed molecular target, Aurora shall provide to Merck an estimate of the approximate resources required for such screen development and shall notify Merck as to whether Aurora accepts such proposed target; provided, however, that Aurora may only reject a proposed target if it reasonably believes that the development of a Collaborative Screen for such proposed target (i) would be inconsistent with Aurora's Third Party obligations, (ii) would cause Aurora to infringe the intellectual property rights of a Third Party, (iii) would require more than two FTEs for twelve months or (iv) would not be feasible in view of the resources and expertise required to complete such Collaborative Screen . Merck and Aurora will repeat the foregoing selection procedure ("Selection Procedure") and will use reasonable efforts, to select at least three (3) molecular targets, for the Annual Work Plan for each year, for which screen development shall be initiated ***.
Sample 1
Screen Selection. Attached as Exhibit A is a list of ***P&U Targets for Collaborative Screen development. Additional potential P&U Targets may be presented by P&U to Aurora during the Collaboration Period. The ***and those subsequently proposed in writing by P&U ***that P&U reasonably believes to be amenable for development for a high throughput screen using Aurora Technology. Aurora may reasonably request further information regarding the ***. Within ***days of first receiving such information, Aurora shall notify P&U in writing in the event that Aurora reasonably believes that the development of a Collaborative Screen ***is not consistent with Aurora's Third Party obligations or if Aurora believes that the development of a *** not reasonably be scientifically ***feasible based on available information and that information provided by P&U. If Aurora *** proposed by P&U, Aurora will provide P&U with reasons for declining to work on the proposed target, to the extent that Aurora does not have to reveal confidential information of a Third Party, waive attorney client privilege ***. Consequently, ***Aurora may not have to provide ***.
Sample 1
Screen Selection 
Sample 1Sample 2Sample 3

Related to Screen Selection

  • Supplier Selection If Customer selects a seat or galley supplier that is not on the Boeing recommended list, such seat or galley will become BFE and the provisions of Exhibit A, Buyer Furnished Equipment Provisions Document, of the AGTA will apply.

  • Adverse Selection No selection procedures adverse to the Noteholders or the Insurer were utilized in selecting the Receivables from those receivables owned by the Seller which met the selection criteria contained in the Sale and Servicing Agreement.

  • Mortgagor Selection No Mortgagor was encouraged or required to select a Mortgage Loan product offered by the Originator which is a higher cost product designed for less creditworthy mortgagors, unless at the time of the Mortgage Loan's origination, such Mortgagor did not qualify taking into account credit history and debt-to-income ratios for a lower-cost credit product then offered by the Originator or any Affiliate of the Originator. If, at the time of loan application, the Mortgagor may have qualified for a lower-cost credit product then offered by any mortgage lending Affiliate of the Originator, the Originator referred the related Mortgagor's application to such Affiliate for underwriting consideration;

  • Selection Criteria Each Contract is secured by a new or used Motorcycle. No Contract has a Contract Rate less than 1.00%. Each Contract amortizes the amount financed over an original term no greater than 84 months (excluding periods of deferral of first payment). Each Contract has a Principal Balance of at least $500.00 as of the Cutoff Date.

  • Financial Market Service Bloomberg Financial Service and any other financial information provider designated by the Depositor by written notice to the Trustee.

  • Selection Process The Mortgage Loans were selected from among the outstanding one- to four-family mortgage loans in the Seller's portfolio at the related Closing Date as to which the representations and warranties set forth in Subsection 9.02 could be made and such selection was not made in a manner so as to affect adversely the interests of the Purchaser;

  • Selection Procedures In selecting the Loan Assets to be Pledged pursuant to this Agreement, no selection procedures were employed which are intended to be adverse to the interests of the Lenders.

  • Rate Quotations The Borrower may call the Administrative Agent on or before the date on which a Loan Request is to be delivered to receive an indication of the rates then in effect, but it is acknowledged that such projection shall not be binding on the Administrative Agent or the Lenders nor affect the rate of interest which thereafter is actually in effect when the election is made.

  • Statistical, Demographic or Market-Related Data All statistical, demographic or market-related data included in the Registration Statement, the Disclosure Package or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate and all such data included in the Registration Statement, the Disclosure Package or the Prospectus accurately reflects the materials upon which it is based or from which it was derived.

  • Election Procedures Each holder of record of shares of Company Common Stock (“Holder”) shall have the right, subject to the limitations set forth in this Article II, to submit an election in accordance with the following procedures:

Time is Money Join Law Insider Premium to draft better contracts faster.